help button home button Am J Pathol JNCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benavides, F.
Right arrow Articles by Conti, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benavides, F.
Right arrow Articles by Conti, C. J.
(American Journal of Pathology. 2002;161:693-703.)
© 2002 American Society for Investigative Pathology

Animal Models

Impaired Hair Follicle Morphogenesis and Cycling with Abnormal Epidermal Differentiation in nackt Mice, a Cathepsin L-Deficient Mutation

Fernando Benavides*, Matthew F. Starost{dagger}, Mónica Flores*, Irma B. Gimenez-Conti*, Jean-Louis Guénet{ddagger} and Claudio J. Conti*

From the Science Park-Research Division,*The University of Texas M. D. Anderson Cancer Center, Smithville, Texas; the Science Park Department of Veterinary Sciences,{dagger}Bastrop, Texas; and the Unité de Génétique des Mammifères,{ddagger}Institut Pasteur, Paris, France

Abstract

We previously described an autosomal-recessive mutation named nackt (nkt) exhibiting partial alopecia associated with CD4+ T-cell deficiency. Also, we recently reported that nkt (now Ctslnkt) comprises a deletion in the cathepsin L (Ctsl) gene. Another recent study reported that Ctsl knockout mice have CD4+ T-cell deficiency and periodic shedding of hair, which recapitulate the nkt mutation and the old furless (fs) mutation. The current study focuses on the dermatological aspects of the nkt mutation. Careful histological analysis of skin development of homozygous nkt mice revealed a delayed hair follicle morphogenesis and late onset of the first catagen stage. The skin of Ctslnkt/Ctslnkt mice showed mild epidermal hyperplasia and hyperkeratosis, severe hyperplasia of the sebaceous glands, and structural alterations of hair follicles. Epidermal differentiation seems to be affected in nkt skin, with overexpression of involucrin and profilaggrin/filaggrin along with focal areas of keratin 6 expression in the interfollicular epidermis. Severe epidermal hyperplasia, acanthosis, orthokeratosis, and hyperkeratosis were only observed in mice maintained in nonpathogen-free environments. The analysis of Rag2-/- Ctslnkt/Ctslnkt double-mutant mice indicates that the skin defect remains under the absence of T and B cells. This animal model provides in vivo evidence that cysteine protease cathepsin L plays a critical role in hair follicle morphogenesis and cycling, as well as epidermal differentiation.

The molecular mechanisms that control epidermal differentiation, hair follicle (HF) morphogenesis, and its cyclic transformation in mammals are not yet fully understood. In this regard, the availability of many transgenic, knockouts, and spontaneous mutant mice exhibiting hair growth and skin defects has been pivotal in the understanding of HF and epidermal biology.1-3 The autosomal-recessive mutation nackt (nkt) shows a delay in the appearance of the first pelage and a sparse hair coat with partial alopecia (focalized on the back) throughout life, as well as CD4+ T-cell deficiency. The nkt trait has 100% penetrance and no genetic modifiers were detected affecting expressivity or pleiotropy, because no phenotype modifications were observed in different genetic backgrounds, including wild-derived inbred mice.4,5 The nkt mutation comprises a deletion in the cathepsin L (Ctsl) gene (a lysosomal cysteine protease) with no functional protein present, rendering the mutation a spontaneous functional knockout for the Ctsl gene. Because the mutated gene is now known, the complete gene symbol is Ctslnkt. We mapped the mutant allele to mouse chromosome 13 (37 cM) and in that way refined the mapping of the Ctsl gene.5 Mouse Ctsl gene mapping had been previously reported by Pilz and collaborators6 based on specific backcross linkage analysis, and later by Deussing and colleagues7 using a panel of BXD recombinant inbred strains. The Ctsl locus is located in a region of mouse chromosome 13 that shows synteny homology with a region on human chromosome 9. The human CTSL gene has been localized in this conserved syntenic region at 9q21-q22.8

Cathepsins are a family of lysosomal proteases with aspartyl and cysteinyl members that are believed to be involved in extracellular and intracellular protein degradation as well as in a range of cellular processes such as major histocompatibility complex antigen presentation and bone remodeling.9 There are currently two known aspartyl (cathepsins D and E) and 11 known cysteinyl (cathepsins B, H, L, S, C, K, O, F, V, X, and W) lysosomal proteases. Cathepsins L (CTSL) and B (CTSB) are, together with aspartyl protease cathepsin D (CTSD), the most abundant lysosomal proteases. Using Ctsl knockout mice, Nakagawa and collaborators10 recently found that CTSL is critical for degradation of invariant chain, a critical chaperone for major histocompatibility complex class II molecules, in cortical thymic epithelial cells. In addition, Ctsl knockout mice experience CD4 deficiency and periodic shedding of hair with abnormal skin morphology, a phenotype that is reminiscent of the nkt and fs mutants.11 More recently, Roth and colleagues12 have described the deficiency of CTSL as the molecular defect underlining the fs (a loss of function mutation of Ctsl) and Ctsl-/- mouse skin phenotypes. Thus, CTSL was the first lysosomal proteinase to be implicated as an essential component of the epidermal homeostasis and HF morphogenesis and cycling.

So far, all of the studies comprising Ctslnkt/Ctslnkt mice (hereafter abbreviated nkt/nkt) have been concentrated on the CD4+ T-cell deficiency. Thus, the mechanism of the hair loss and cycling defects in nkt/nkt mice has never been described. The dermatological aspects of the nkt mutation presented here are an initial effort to address the questions regarding the role of CTSL in HF morphogenesis and cycling, as well as epidermal differentiation in the nkt skin. Although reminiscent of the Ctsl-/- phenotype, the nkt mice present unique characteristics, such as the hyperplasia of sebaceous glands, which can be attributed to the nature of the mutation. We present, for the first time, a thorough description of the skin phenotype using various and well-defined genetic backgrounds on a specific pathogen-free (SPF) as well as conventional (nonpathogen-free) environment. We used a genetic approach to prove that the skin phenotype is the direct effect of a deficiency of CTSL on the skin and not an epiphenomenon of the immunological phenotype. Our observations from the nkt skin suggest a role of CTSL in the terminal differentiation of keratinocytes in the epidermis, as well as HF morphogenesis and cycling. The processing of profilaggrin to filaggrin and the final proteolytic steps of filaggrin degradation seems to be impaired in the nkt skin, leading to a delay in transit from stratum granulosum to stratum corneum. This mouse mutation may provide a good model for the study of human disorders involving alopecia, sebaceous gland hyperplasia, hyperkeratosis, and defective differentiation of the epidermis.

Materials and Methods

Animal Model and Skin Samples

The nkt mutant allele arose in 1981, in the laboratory animal facilities of the Martin-Luther-Universität in Halle-Wittenberg (Germany). A pair of mutant mice was introduced into the animal facility of the Institut Pasteur, Paris, France, in 1991, where they were crossed to 129S2/SvPas inbred breeders for a few generations and then intercrossed. Mice segregating for nkt were transferred to the animal facilities of the Instituto de Investigaciones Hematológicas, Buenos Aires, Argentina, where the mutant allele was backcrossed onto two new backgrounds (BALB/c and C57BL/6) by performing, in each case, four successive rounds of cross-intercross (N4). Finally, these N4 mice segregating for nkt were transferred to the M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, TX, where we continued backcrossing onto BALB/c and C57BL/6 backgrounds (currently in N9). (Nomenclature for these congenic strains is BALB/c.Cg-Ctslnkt and C57BL/6.Cg-Ctslnkt). We have also collected data for the description of the gross appearance of nkt animals from MAI/Pas, MBT/Pas, and CAST/Ei wild-derived inbred strains (used in the genetic mapping project) and partially congenic DBA/2-nkt (N4) mice. BALB/c-Rag2-/- (C.129S6(B6)-Rag2tml) congenic mice were purchased from Taconic Farms (Germantown, NY).

For studies of HF morphogenesis and cycling, groups of three male and three female mice at 0, 3, 6, 9, 12, 15, 18, 21, 24, 27, and 30 days postpartum from nkt/nkt and +/nkt? littermates (BALB/c and C57BL/6 backgrounds) were used, to cover the first hair cycle.13 Skin specimens were harvested from these mice as well as from adult mice at 6 weeks and 6 months of age, including homozygous and heterozygous mutant animals as well as wild-type. Skin collection was also done at 2, 3, and 6 weeks of age from BALB/c-Rag2-/-; nkt/nkt double-mutant mice. Animals were sacrificed by CO2 asphyxiation and skin samples from the dorsum, ventrum, muzzle, ear, eyelid, footpad, and tail were collected in Fekete’s acid-alcohol formalin fixative. Within 12 hours of collection the samples were fixed in 70% ethanol, then embedded, sectioned, and processed for hematoxylin and eosin (H&E) and Giemsa staining as described by Sundberg and Boggess.14 Heads, as well as front and rear feet, whole mounts were previously decalcified. For hair studies, hair samples were plucked (truncal hair) from around the alopecic areas and normal areas and examined by light microscopy. Complete sets of organs were collected, fixed, processed, and stained with H&E for histopathological examination from mice at the referred ages. The stages of HF morphogenesis and cycling were assessed according to Paus and colleagues15 and Sundberg and King,13 respectively, in 50 HFs per animal.

Bromodeoxyuridine (BrdU) Labeling

Epithelial cell proliferation was measured by intraperitoneal injection of BrdU (60 µg/g; Sigma Chemical Co., St. Louis, MO) 30 minutes before the mice were sacrificed. Dorsal and ventral skin from both mutant and control animals were collected and fixed with 4% paraformaldehyde, dehydrated, and embedded in paraffin. After sectioning, the slides were dewaxed and denatured in 1.5 mol/L of HCl for 30 minutes and neutralized with phosphate-buffered saline for 1 hour. BrdU incorporation was detected by immunohistochemical staining of paraffin-embedded sections with mouse anti-BrdU monoclonal antibody (Becton-Dickinson Immunocytometry System; Becton-Dickinson, San Jose, CA). The reaction was visualized with a biotin-conjugated anti-mouse antibody (Vector Laboratories, Inc., Burlingame, CA) and avidin-biotin-peroxidase kit (Vectastain Elite, Vector Laboratories, Inc.) with diaminobenzidine as chromogen, as previously described.16

Immunohistochemistry

Dorsal skin from nkt/nkt and +/nkt? control mice was fixed in 70% ethanol or snap-frozen (embedded in OCT) in liquid nitrogen for immunohistochemistry immediately after the mice were sacrificed. Longitudinal cryosections (8-µm thick) were fixed in acetone for 10 minutes at -20°C and air-dried at room temperature for 6 hours. Immunohistochemical staining of ethanol-fixed paraffin-embedded tissues was performed with polyclonal antibodies directed against mouse keratins K1, K5, K6, K10, K14, loricrin, involucrin, and profilaggrin and filaggrin (Covance Research Products, Richmond, CA), and Cd31 (PharMingen, San Diego, CA) as previously described.17-20 We assessed standard microvessel density with the anti-Cd31 (platelet/endothelial cell adhesion molecule) monoclonal antibody as previously described.21 Controls in the absence of primary antibodies were routinely performed. To determine whether possible changes in expression of these epidermal proteins were solely because of the epidermal hyperplasia displayed by the nkt skin, we included in our studies 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced epidermal hyperplasias. The samples used for the hyperplastic skin analysis were a gift from Dr. I. B. Gimenez-Conti. For this purpose, SENCAR mice were treated topically twice a week with 5 g of TPA (Sigma Chemical Co.) per animal.

Western Blotting

Protein was isolated from separated dorsal epidermis of nkt mutants and control mice using RIPA lysis buffer (150 mmol/L NaCl, 1.0% Nonidet P-40, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate, 50 mmol/L Tris, pH 8.0) and run on a 10% Tris-glycine gel obtained from Novex (San Diego, CA). Protein concentration was estimated using the Bradford reagent obtained from Sigma (The Woodlands, TX) and an Eppendorf Biophotometer (Brinkmann, Westbury, NY). Polyclonal rabbit anti-mouse keratins K1, K5, K6, K10, K14, loricrin, involucrin, and profilaggrin and filaggrin antibodies were obtained from Covance Research Products. Binding of antibodies was detected using ECL+Plus Western blotting detection system (Amersham Pharmacia Biotech UK Limited, Buckinghamshire, UK). We also included TPA-induced epidermal hyperplasia in the Western blot studies. Protein extracts were a gift of Dr. J. DiGiovanni (Science Park Research Division, M.D. Anderson Cancer Center, Smithville, TX) (obtained from whole skin of FVB/N mice with four treatments of 3.4 nmol of TPA throughout 2 weeks).

Results

Gross Observation and Clinical Features

From the time of birth until approximately 7 days of age, mutant nkt mice appeared runted in comparison with littermate controls (Figure 1A) . At postnatal days 5 to 6, the skin of heterozygous littermates showed the first pelage hairs emerging through the epidermis, whereas homozygous mutants remained completely naked. The first hair coat in nkt/nkt mice developed at approximately day 7 of age and continued to be sparse during the entire life span of the animals. In contrast to Ctsl-/- and fs/fs mice, described by Roth and collaborators,12 mutant nkt mice never show a normal, healthy fur. Figure 1B shows the sparse coat phenotype of a 15-day-old BALB/c-nkt/nkt animal. The gross appearance of adult nkt mice was always associated with focal alopecia and completely bald patches around the eyes and the cranial region of the dorsum (Figure 1C) . Homozygous nkt mice have normal vibrissae, eyelids, and nails. Heterozygous nkt mice were indistinguishable from wild-type age-matched mice at all ages.



View larger version (99K):
[in this window]
[in a new window]
  		Figure 1. Skin phenotype of Ctslnkt/Ctslnkt mice. A: BALB/c-Ctslnkt/Ctslnkt mouse (left) is runted at day 3 postpartum compared with age- and sex-matched littermate controls (right). The first hair coat in mutant mice develops at approximately day 7 postpartum and continues to be sparse during the entire life span of the animals. B: Sparse coat phenotype of a BALB/c-Ctslnkt/Ctslnkt mouse (right) at day 15 postpartum. C: Focal alopecia of the cranial region of the dorsum in a BALB/c-Ctslnkt/Ctslnkt mouse (front) at day 90 postpartum. D: Self-inflicted lesions and skin ulcerations in a 9-month-old MAI/Pas-Ctslnkt/Ctslnkt mouse maintained in non-SPF environment.

 
When maintained in non-SPF facilities (albeit free of ectoparasites), nkt/nkt mice were nearly devoid of hair at 3 weeks of age. By 3 months of age, the mutant mice were severely pruritic based on intense scratching by the animals, suggesting the association of bacterial or fungal infections. This often resulted in self-inflicted lesions that evolved into dermatitis and ulceration (Figure 1D) . In older animals, these lesions were always associated with enlargement of the regional lymph nodes (especially of the head, neck, and hind limb regions). This dermatopathic lymphadenitis was associated with the generalized exfoliative dermatitis originated from the chronic pruritus.

HF Morphogenesis and Cycling

Histological examination of the skin revealed differences between homozygous and control mice (maintained in SPF conditions) in the morphology of the developing HFs. Day 6 homozygous nkt mice showed a delay in the morphogenesis compared with littermate controls, confirming the macroscopic observation. Following the guidelines proposed by Paus and colleagues,15 we determined that 80% of the mutant HFs were on stage 6 whereas 60% of wild-type HFs were clearly at stage 8 (Figure 2, A and B) . Also, the onset of the first catagen cycle was delayed in day 21 postpartum nkt/nkt mice. Approximately 60% of HFs in wild-type back skin had already reached the end of catagen of the first hair cycle. In contrast, only 30% of nkt/nkt follicles had completed catagen development (Figure 2, C and D) . Also, homozygous mutant mice exhibited a reduced HF density (data not shown).



View larger version (185K):
[in this window]
[in a new window]
  		Figure 2. Delayed HF morphogenesis and sebaceous gland hyperplasia in BALB/c-Ctslnkt/Ctslnkt mice. A: Histological analysis of day 6 postpartum sections of mutant back skin shows that most of the HFs are on stage 6 of morphogenesis.15 B: Skin sections of age- and sex-matched littermate controls show HFs at stage 8 (hair shaft emerging through the epidermis) (H&E; original magnifications, x200). C: Day 21 postpartum sections of mutant back skin show a delay in catagen progression compared with age- and sex-matched littermate controls (D). Also note the presence of hyperplastic epidermis (arrow) and thickened dermis in homozygous compared to control mice (H&E, original magnifications, x100). E: Marked hyperplasia of sebaceous gland in day 15 postpartum mutant mice compared with age- and sex-matched littermate controls (F) (H&E; original magnifications, x200). E, epidermis; D, dermis; SG, sebaceous gland.

 
Microscopic Description

At approximately day 15 postpartum, the presence of large sebaceous glands in homozygous compared to control mice (maintained in SPF conditions) was evident (Figure 2, E and F) . This is a prominent feature that was not described in the skin of fs/fs and Ctsl-/- mutant mice.12 Also beginning at approximately day 15, the epidermis of nkt mutant mice was moderately hyperplastic and mildly acanthotic and showed various degrees of orthokeratotic hyperkeratosis with the presence of scattered keratin plugs. However, epithelial cell proliferation measured by BrdU labeling did not reveal significant differences between mutant and wild type (data not shown). Standard microvessel density measured with anti-Cd31 monoclonal antibody did not reveal significant differences between mutant and control mice (data not shown). Scant numbers of HFs, often devoid of hair shafts and moderately atrophic, were also observed in the nkt skin. Hair shafts were defective (often twisted) with dilation of the hair canal and showed occasional adherent keratinous debris. Mutant nkt mice seemed to have a propensity for follicular accumulation of keratin. External ear canals were filled with excess keratin, and the nonglandular stomach showed mild hyperplasia with orthokeratosis. The dermis of SPF homozygous mutant mice appeared slightly thickened and showed long stretches without HFs (Figure 2C) . Giemsa staining of mast cells did not reveal significant differences between mutant and control mice (data not shown).

Histologically, the epidermis of mutant mice maintained in non-SPF (conventional) conditions appeared severely hyperplastic with acanthosis and/or hypergranulosis, or epidermal and follicular orthokeratosis. The propensity for follicular and sebaceous gland accumulation of keratin sometimes led to furunculosis and abscesses of the preputial glands. Multifocal areas of serocellular crust formation were observed on the skin of older animals. The dermis showed marked infiltration of inflammatory cells such as lymphocytes, mast cells, and polymorphonuclear cells. There was also marked hyperplasia of the sebaceous gland, which was presumably enhanced as a consequence of the dermatitis. Skin lesions were consistently less severe in the ventral region than in other parts of the body. Homozygous nkt mice frequently developed opacification of the cornea with a rather heterogeneous phenotype along with keratitis and ulceration. In aged nkt mice (approximately 1 year old), multifocal areas of necrosis were found in the periodontal ligament and pulp cavity of molars, along with cementum resorption.

Keratin Expression

To further investigate the mechanisms involved in the defective epidermal differentiation of the nkt skin, we performed immunohistochemistry with antibodies against K1, K5, K6, K10, and K14.22 Immunohistochemical analysis of 21-day-old nkt/nkt back skin with markers against K1, K5, K10, and K14 showed no significant differences between nkt/nkt mice and littermate controls. We found that in back skin from 21-day-old nkt/nkt mice, K6 expression is present in the HFs and also in the interfollicular epidermis as focal areas around the HF. As shown in Figure 3A , nkt/nkt skin exhibits K6-positive keratinocytes emerging from the HF to the epidermis, a feature not found in age- and sex-matched littermate controls. In normal untraumatized skin, K6 expression is restricted to specialized cells of the HF, particularly a single cell layer that surrounds the innermost layer of the outer root sheath. However, inducible expression in the interfollicular epidermis takes place in response to stressful stimuli or exposure of phorbol esters.23 This feature of the nkt skin implies altered epidermal differentiation and suggests that the re-epithelialization process of the mutant hyperplastic epidermis originates from the HF keratinocytes. By Western blotting, we could confirm that expression of K6 was higher in the nkt skin, compared to TPA-induced hyperplastic skin. However, we found no significant differences between nkt/nkt mice and littermate controls in the expression of K1, K5, K10, and K14 (Figure 4) .




View larger version (205K):
[in this window]
[in a new window]
  		Figure 3. Histology and immunohistochemistry of BALB/c-Ctslnkt/Ctslnkt mouse epidermis. H&E staining and immunohistochemistry of normal (BALB/c-+/nkt?), hyperplastic (TPA-treated SENCAR mice), and nackt (BALB/c-nkt/nkt) dorsal skin. A: Note high levels of involucrin expression in the epidermis and K6 expression in the interfollicular epidermis in nkt/nkt skin. B: Note the marked increase of profilaggrin and filaggrin expression in nkt/nkt epidermis. Original magnifications: x200, except profilaggrin and filaggrin x200 and x400. Immunohistochemistry was performed with loricrin, involucrin, K6, K10, K14, and profilaggrin and filaggrin antibodies.

 


View larger version (36K):
[in this window]
[in a new window]
  		Figure 4. BALB/c-Ctslnkt/Ctslnkt epidermis expresses high levels of involucrin, K6, and profilaggrin/filaggrin. Western blot analyses were done with normal (+/+ and +/nkt) and nkt/nkt epidermis from day 21 postpartum mice, and hyperplastic skin (HS) from adult FVB/N mice treated with TPA. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and blotted onto nitrocellulose membrane. Note overexpression of involucrin and K6 as well as the marked overexpression of high molecular weight profilaggrin (PF), filaggrin (F), and its processing intermediates (I) in nkt/nkt epidermis. Filaggrin (27 kd in the mouse) is synthesized as a high molecular weight precursor, profilaggrin (>200 kd), which is subsequently processed. The nkt/nkt epidermis seems to have a defect in the processing of profilaggrin to filaggrin and its final proteolytic degradation. Western blot was performed with involucrin, K6, profilaggrin/filaggrin, and actin (loading control) primary antibodies as described in Materials and Methods.

 
Involucrin, Loricrin, and Profilaggrin/Filaggrin Expression

A panel of antibodies was used to evaluate, by immunohistochemistry, the expression of mouse-specific epidermal involucrin, loricrin, and profilaggrin/filaggrin in mutant and control mice. Involucrin was weakly positive in the upper epidermis in normal skin; however, in nkt/nkt mice, the epidermis exhibited a marked positive signal with a diffuse staining of the lower layers and sebaceous gland. TPA-induced hyperplastic epidermis also showed a strong signal in most of the suprabasal layers as previously reported (Figure 3A) .24 Late marker loricrin was expressed in similar patterns in both mutant and control mice, but was slightly overexpressed in the TPA-induced hyperplastic epidermis (Figure 3A) . Profilaggrin and filaggrin were expressed in keratohyaline granules in normal skin and TPA-induced hyperplastic skin, but the signal was more prominent in the latter (Figure 3B) . In nkt/nkt mice, profilaggrin/filaggrin were strongly overexpressed on the granular layer and showed a diffuse staining in most of the suprabasal layers of the epidermis and in the sebaceous glands (Figure 3B) . To determine this further, immunoblot analysis was performed using epidermal extracts prepared from dorsal skins of normal (+/+ and +/nkt), TPA-treated, and nkt/nkt mice. Involucrin was overexpressed at high levels in nkt/nkt mice, compared to normal and even hyperplastic skin (Figure 4) . Further, the nkt epidermis showed a significant increase in profilaggrin, filaggrin intermediates, and filaggrin, suggesting a defect in the processing of profilaggrin to filaggrin and the final proteolytic steps of filaggrin degradation (Figure 4) .

Rag2-/- Ctslnkt/CtslnktDouble-Mutant Mice Retain the Skin Phenotype

HF cycling in the mouse was previously associated with alterations in the skin immune status, particularly in the number of mast cells, macrophages, and T cells.25 Also, infiltration of lymphocytes in the HF can follow with disruption of its normal function and give rise to defective hair shafts (albeit without hyperplastic epidermis) as was reported in aging C3H/He mice.26 To address the question of the involvement of immunological alterations as possibly being responsible for the skin phenotype of the nkt mice, we developed double mutants harboring a Rag2 null allele and the nkt allele. Gross as well as histological examination of the skin at 2, 3, and 6 weeks of age revealed no differences between homozygous nkt/nkt and Rag2-/- nkt/nkt double-mutant mice (data not shown). This finding demonstrates that the skin defect in the nkt mutant mice is not a lymphocyte-mediated process but a direct effect of the deficiency of CTSL in the skin.

Discussion

Various mouse mutations with anomalies of the hair coat and associated with immunological defects have been previously reported. This is the case for the nude locus (Foxn1nu and Foxn1nu-str), in which affected mice are hairless from birth and suffer from almost complete thymic agenesis.27 The pleiotropic effect of this mutation is explained by the disruption of the Foxn1 gene, a transcription factor expressed specifically in both skin and thymus and required for the proper keratinization of the hair shaft.28 The balding allele (Dsg3bal), a frameshift mutation of the Desmoglein 3 gene, an adhesion molecule, likewise exhibits both hair growth abnormalities and an increase in the number of mast cells in skin with associated elevated IgE levels.29,30 The flaky skin (fsn) mutation, a potential model for human psoriasis, has also elevated serum IgE levels and mast cell accumulation associated with lymphadenopathy.31 Finally, hairless mice (hr and hrrh alleles), which lose their coat after the first hair pelage, have a defective cellular immune response throughout their life. A transcription factor defect irreversibly abrogates the follicle’s capacity to cycle in hr/hr mice.32 These spontaneous mouse mutations, among many others, have been critical in the comprehension of the developmental biology of the HF.2,33,34

We report here the dermatological characteristics of a spontaneous mouse mutation that shows partial alopecia, reduced HF density, and sebaceous gland hyperplasia associated with abnormal epidermal differentiation. This immunodeficient mutation comprises a deletion in the Ctsl gene, a lysosomal cysteine proteinase.4,5 Although the nkt mouse does not represent a model for a particular inherited human skin disease, mutant mice exhibit morphological similarities that correlate with different human disorders and offer a potential model to study their biochemical mechanisms (Table 1) . The potential use of experimentally infected nkt mice as a model for the study of dermatitis associated with infections in immunodeficient individuals (eg, HIV-associated dermatitis) remains to be evaluated.


View this table:
[in this window]
[in a new window]
  		Table 1. Comparison of Features of nkt/nkt Mice and Human Skin Disorders

 
Papain-like cysteine proteinases have long been associated with terminal degradation of proteins in the lysosomal compartment. However, recent findings have highlighted the existence of more specific functions of these enzymes, such as antigen processing and presentation, osteoclastic bone resorption, and cancer invasion.35 In particular, CTSL has been shown to be essential for antigen processing in cortical thymic epithelial cells as well as epidermal homeostasis and HF morphogenesis and cycling.10,12,36 In the skin, catagen was previously associated with extracellular matrix remodeling and condensation of the dermal papilla, and intrafollicular and perifollicular protease-anti-protease systems have been implicated in the control of this remodeling process.37,38 Involvement of lysosomal proteolysis-associated macrophages in the sequence of morphological and pigmentary changes during the anagen to catagen transformation was also suggested.25,39 A number of different proteases have been shown to play a role in epidermal differentiation, including calpain I and cathepsins B, C, H, and L.40 Aspartic protease CTSD was proposed to play a role as a proteolytic agent of desquamation in human skin.41 Furthermore, activated forms of CTSL, along with CTSB and CTSD, were proposed to play a role in the pathogenesis of psoriatic epidermis.42 Roth and collaborators12 postulated that in the absence of CTSL, the skin phenotype of Ctsl-/- mice is because of hyperproliferation of HF epithelial cells and basal keratinocytes. In addition, using CTSL-deficient fibroblasts from Ctsl-/- mice, Zwad and collaborators43 showed transient accumulation of insulin-like growth factor-1 binding protein-3 in the endosomal and lysosomal compartments. This observation suggested that CTSL might play a role in the balance between proliferation and differentiation of epithelial cells through insulin-like growth factor-1.

During terminal differentiation of keratinocytes, profilaggrin (found in keratohyalin granules) is processed to functional filaggrin, which binds to keratin filaments.44,45 Recently, it was proposed that filaggrin is susceptible to degradation by an epidermal CTSL-like proteinase in the rat, suggesting that this proteolytic activity may have relevance to skin differentiation.46 By immunohistochemistry, we showed that K1, K10, K14, and loricrin expression follow predictable patterns in hyperplastic skin, with similar patterns in the hyperplastic epidermis of nkt mice, namely, increase in K14 expression, results confirmed by Western analysis. However, expression of K6 in the interfollicular epidermis, increased levels of involucrin, and strong overexpression of filaggrin was observed only in the nkt skin by immunohistochemistry. By Western blotting, we confirm an increase in K6 and involucrin expression as well as a significant increase in profilaggrin, filaggrin intermediates, and filaggrin in the nkt epidermis. Our results suggest that CTSL is playing a role in the conversion of profilaggrin to filaggrin as well as the degradation of filaggrin to free amino acids in the stratum corneum during keratinization. The increase in the number of cells expressing filaggrin in the upper layers of the epidermis suggests a delay in the transit of filaggrin from the stratum granulosum to the stratum corneum. However, the mild epidermal hyperplasia seems to be the result of a disturbed program of epidermal differentiation rather than an increase in the proliferation rate, because the total number of proliferating cells (as measured by BrdU labeling) in the nkt skin was comparable to control mice. This is supported by previous evidence that expression of K6 is not directly linked to hyperproliferation but indirectly to altered epidermal differentiation.23 Thus, the hyperkeratosis may result from a decelerated desquamation rather than an accelerated cornification process. Similar increases in profilaggrin, filaggrin intermediates, and filaggrin were reported in human patients with epidermolytic hyperkeratosis (also called bullous congenital ichthyosiform erythroderma or BCIE).47 Increases in involucrin, filaggrin, and K6 have been reported also in K10-deficient mice, an animal model for human BCIE.48,49

Recently, the importance of proteases in epidermal differentiation was emphasized by the discovery of null mutations of the human cathepsin C (CTSC) gene that result in rare palmoplantar keratoderma disorders, such as Hain-Munk and Papillon-Lefèvre syndromes.50,51 Within the first 3 years of life, Papillon-Lefèvre syndrome patients show severe periodontitis resulting in premature tooth loss and palmoplantar keratosis, varying from mild psoriasiform skin to manifest hyperkeratosis. Most Papillon-Lefèvre syndrome patients display both periodontitis and hyperkeratosis, but some of them have only palmoplantar keratosis or periodontitis. However, Ctsc-/- mice develop normally and do not exhibit periodontal disease or hyperkeratosis, at least under pathogen-free conditions. Nevertheless, their cytotoxic T lymphocytes and lymphokine-activated killer cells lack cytotoxic activity because of defective processing and activation of granzymes A and B.52 Interestingly, the nkt mice maintained under non-SPF conditions display some characteristics of Papillon-Lefèvre syndrome human patients, such as epidermal hyperkeratosis and dental disease, albeit with later onset. It remains to be elucidated whether, in the mouse, CTSL has complementary functions with CTSC.

Although allelic variants of the Ctsl gene, some aspects of the skin phenotype of nkt mice differ from the descriptions using Ctsl-/- and fs/fs mice. For instance, the marked hyperplasia of the sebaceous glands is an early event (day 15 postpartum) in the nkt mice and has not been described in the other Ctsl-deficient mouse models. The human skin disease nevus sebaceus of Jadassohn exhibit massive development of sebaceous glands, with epidermal, follicular, and apocrine gland abnormalities.53 The only animal model for nevus sebaceus of Jadassohn was described by Prouty and colleagues54 using a nude mouse grafting model. Thus, the nkt mutation may provide a useful model for the study of human diseases associated with sebaceous gland hyperplasia.

In conclusion, we have described in this study the skin phenotype of the nkt mouse mutation. The nkt mutation represents a potential animal model to investigate the biochemical mechanisms involved in human diseases with abnormal HFs, epidermis, and sebaceous glands. This is sustained by the availability of the mutant allele in well-defined full-congenic strains maintained in SPF conditions. In addition, we excluded the immunological factors as a potential cause of the nkt skin phenotype by crossbreeding in vivo experiments using T- and B-cell-deficient Rag2 null mice with nkt/nkt mice. Finally, the data reported here provide further evidence in vivo that the lysosomal cysteine protease CTSL plays a critical role in HF morphogenesis, cycling, and epidermal differentiation, and that CTSL is required, but not essential, for an efficient degradation of profilaggrin and filaggrin.

Acknowledgements

We thank Debra Hollowell for re-derivations of nkt mice by embryo transfer; Dr. Lezlee Coghlan, Dale Weiss, Pam Kille, Donna Schutz, and Carla Webb for assistance with maintenance of breeding colonies; Dr. John DiGiovanni and Steve Carbajal for the gift of protein extracts from hyperplastic skin; the Histology Service of Science Park-Research Division for processing the samples; Melissa Bracher for secretarial assistance; and Sharon Stockman for editing this manuscript.

Footnotes

Address reprint requests to Fernando Benavides, D.V.M., Ph.D., The University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville, TX 78957. E-mail: fbenavides{at}sprd1.mdacc.tmc.edu

Supported by grant CA69146 from the National Institutes of Health (to C. J. C.).

Accepted for publication April 25, 2002.

References

  1. Yamanishi K: Gene-knockout mice with abnormal epidermal and hair follicular development. J Dermatol Sci 1998, 18:75-89[Medline]
  2. Sundberg JP: Handbook of Mouse Mutations with Skin and Hair Abnormalities: Animal Models on Biomedical Tools. 1994 CRC Press, Inc., Boca Raton
  3. Sundberg JP, King LE, Jr: Mouse mutations as animal models and biomedical tools for dermatological research. J Invest Dermatol 1996, 106:368-376[Medline]
  4. Benavides F, Giordano M, Fiette L, Bueno Brunialti AL, Martin Palenzuela N, Vanzulli S, Baldi P, Schmidt R, Dosne Pasqualini C, Guénet J: Nackt (nkt), a new hair loss mutation of the mouse with associated CD4 deficiency. Immunogenetics 1999, 49:413-419[Medline]
  5. Benavides F, Venable A, Poetschke Klug H, Glasscock E, Rudensky A, Martin Palenzuela N, Guénet J-L, Richie E, Conti CJ: The CD4 T cell deficient mouse mutation. Nackt (nkt) involves a deletion in the cathepsin L gene (Ctsl). Immunogenetics 2001, 53:233-242[Medline]
  6. Pilz A, Woodward K, Povey S, Abbott C: Comparative mapping of 50 human chromosome 9 loci in the laboratory mouse. Genomics 1995, 25:139-149[Medline]
  7. Deussing J, Roth W, Rommerskirch W, Wiederanders B, von Figura K, Peters C: The genes of the lysosomal cysteine proteinases cathepsin B, H, L and S map to different mouse chromosomes. Mamm Genome 1997, 8:241-245[Medline]
  8. Chauhan SS, Popescu NC, Ray D, Fleischmann R, Gottesman MM, Troen BR: Cloning, genomic organization, and chromosomal localization of human cathepsin L. J Biol Chem 1993, 268:1039-1045[Abstract/Free Full Text]
  9. Riese RJ, Chapman HA: Cathepsins and compartmentalization in antigen presentation. Curr Opin Immunol 2000, 12:107-113[Medline]
  10. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, Deussing J, Villadangos JA, Ploegh H, Peters C, Rudensky AY: Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998, 280:450-453[Abstract/Free Full Text]
  11. Green EL: The genetics of a new hair deficiency, furless. J Hered 1954, 45:115-118[Abstract/Free Full Text]
  12. Roth W, Deussing J, Botchkarev VA, Pauly-Evers M, Saftig P, Hafner A, Schmidt P, Schmahl W, Scherer J, Anton-Lamprecht I, Von Figura K, Paus R, Peters C: Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and perturbation of hair follicle cycling. EMBO J 2000, 14:2075-2086
  13. Sundberg JP, King LE: Skin and its appendages: normal anatomy and pathology of spontaneous, transgenic, and targeted mouse mutations. Ward JM Mahler JF Maronpot RR Sundberg JP eds. Pathology of Genetically Engineered Mice. 1999:pp 183-215 Iowa State University Press, Ames
  14. Sundberg JP, Boggess D: Systematic Approach to Evaluation of Mouse Mutations. 2000 CRC Press, Inc., Boca Raton
  15. Paus R, Muller-Rover S, Van Der Veen C, Maurer M, Eichmuller S, Ling G, Hofmann U, Foitzik K, Mecklenburg L, Handjiski B: A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol 1999, 113:523-532[Medline]
  16. Rodriguez-Puebla ML, LaCava M, Miliani De Marval PL, Jorcano JL, Richie ER, Conti CJ: Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia. Am J Pathol 2000, 157:1039-1050[Abstract/Free Full Text]
  17. Roop DR, Cheng CK, Titterington L, Meyers CA, Stanley JR, Steinert PM, Yuspa SH: Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J Biol Chem 1984, 259:8037-8040[Abstract/Free Full Text]
  18. Mahooti S, Graesser D, Patil S, Newman P, Duncan G, Mak T, Madri JA: PECAM-1 (CD31) expression modulates bleeding time in vivo. Am J Pathol 2000, 157:75-81[Abstract/Free Full Text]
  19. Presland RB, Boggess D, Lewis SP, Hull C, Fleckman P, Sundberg JP: Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol 2000, 115:1072-1081[Medline]
  20. Miliani De Marval PL, Gimenez-Conti IB, LaCava M, Martinez LA, Conti CJ, Rodriguez-Puebla ML: Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis. Am J Pathol 2001, 159:369-379[Abstract/Free Full Text]
  21. Koukourakis MI, Giatromanolaki A, Thorpe PE, Brekken RA, Sivridis E, Kakolyris S, Georgoulias V, Gatter KC, Harris AL: Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res 2000, 60:3088-3095[Abstract/Free Full Text]
  22. Fuchs E: Keratins and the skin. Annu Rev Cell Dev Biol 1995, 11:123-153[Medline]
  23. Rothnagel JA, Seki T, Ogo M, Longley MA, Wojcik SM, Bundman DS, Bickenbach JR, Roop DR: The mouse keratin 6 isoforms are differentially expressed in the hair follicle, footpad, tongue and activated epidermis. Differentiation 1999, 65:119-130[Medline]
  24. Li ER, Owens DM, Djian P, Watt FM: Expression of involucrin in normal, hyperproliferative and neoplastic mouse keratinocytes. Exp Dermatol 2000, 9:431-438[Medline]
  25. Stenn KS, Paus R: Controls of hair follicle cycling. Physiol Rev 2001, 81:449-494[Abstract/Free Full Text]
  26. Sundberg JP, Cordy WR, King LE, Jr: Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 1994, 102:847-856[Medline]
  27. Shultz LD, Heiniger HJ, Eicher EM: Immunopathology of streaker mice: a remutation to nude in the AKR/J strain. Gershwing ME Cooper EL eds. Animal Models of Comparative and Developmental Aspects of Immunity and Disease. 1978:pp 211-222 Pergamon Press, New York
  28. Schorpp M, Hofman M, Dear TN, Boehm T: Characterization of mouse and human nude genes. Immunogenetics 1997, 46:509-515[Medline]
  29. Davisson MT, Cook SA, Johonson KR, Eicher EM: Balding: a new mutation on mouse chromosome 18 causing hair loss and immunological defects. J Hered 1994, 85:134-136[Abstract/Free Full Text]
  30. Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Shultz L, Murphy GF, Whitaker-Menezes D, Stanley JR: Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 1997, 137:1091-102[Abstract/Free Full Text]
  31. Pelsue SC, Schweitzer PA, Schweitzer IB, Christianson SW, Gott B, Sundberg JP, Beamer WG, Shultz LD: Lymphadenopathy, elevated serum IgE levels, autoimmunity, and mast cell accumulation in flaky skin mutant mice. Eur J Immunol 1998, 28:1379-1388[Medline]
  32. Panteleyev AA, Botchkareva NV, Sundberg JP, Christiano AM, Paus R: The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol 1999, 155:159-171[Abstract/Free Full Text]
  33. Sundberg JP, King LE, Jr: Mouse mutations as animal models and biomedical tools for dermatological research. J Invest Dermatol 1996, 106:368-376
  34. Luetteke NC, Phillips HK, Qiu TH, Copeland NG, Earp HS, Jenkins NA, Lee DC: The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 1994, 8:399-413[Abstract/Free Full Text]
  35. Calkins CC, Sloane BF: Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol Chem Hoppe Seyler 1995, 376:71-80[Medline]
  36. Nakagawa T, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, McNeish JD, Eastma SE, Howard ED, Clarke SRM, Rosloniec EF, Elliott EA, Rudensky AY: Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999, 10:207-217[Medline]
  37. Paus R: Principles of hair cycle control. J Dermatol 1998, 25:793-802[Medline]
  38. Lindner G, Botchkarev VA, Botchkareva NV, Ling G, van der Veen C, Paus R: Analysis of apoptosis during hair follicle regression (catagen). Am J Pathol 1997, 151:1601-1617[Abstract]
  39. Philpott MF, Paus R: Principles of hair follicle morphogenesis. Chuong CM eds. Molecular Biology of Skin Appendages Morphogenesis. 1998:pp 75-110 RG Landes Company, Austin
  40. Pearton DJ, Nirunsuksiri W, Rehemtulla A, Lewis SP, Presland RB, Dale BA: Proprotein convertase expression and localization in epidermis: evidence for multiple roles and substrates. Exp Dermatol 2001, 10:193-203[Medline]
  41. Horikoshi T, Arany I, Rajaraman S, Chen SH, Brysk H, Lei G, Tyring SK, Brysk MM: Isoforms of cathepsin D and human epidermal differentiation. Biochimie 1998, 80:605-612[Medline]
  42. Kawada A, Hara K, Kominami E, Hiruma M, Noguchi H, Ishibashi A: Processing of cathepsins L, B and D in psoriatic epidermis. Arch Dermatol Res 1997, 289:87-93[Medline]
  43. Zwad O, Kubler B, Roth W, Scharf JG, Saftig P, Peters C, Braulke T: Decreased intracellular degradation of insulin-like growth factor binding protein-3 in cathepsin L-deficient fibroblasts. FEBS Lett 2002, 510:211-215[Medline]
  44. Kuechle MK, Thulin CD, Presland RB, Dale BA: Profilaggrin requires both linker and filaggrin peptide sequences to form granules: implications for profilaggrin processing in vivo. J Invest Dermatol 1999, 112:843-852[Medline]
  45. Presland RB, Kimball JR, Kautsky MB, Lewis SP, Lo CY, Dale BA: Evidence for specific proteolytic cleavage of the N-terminal domain of human profilaggrin during epidermal differentiation. J Invest Dermatol 1997, 108:170-178[Medline]
  46. Kawada A, Hara K, Hiruma M, Noguchi H, Ishibashi A: Rat epidermal cathepsin L-like proteinase: purification and some hydrolytic properties toward filaggrin and synthetic substrates. J Biochem 1995, 118:332-337[Abstract/Free Full Text]
  47. Ishida-Yamamoto A, Eady RA, Underwood RA, Dale BA, Holbrook KA: Filaggrin expression in epidermolytic ichthyosis (epidermolytic hyperkeratosis). Br J Dermatol 1994, 131:767-779[Medline]
  48. Reichelt J, Bussow H, Grund C, Magin TM: Formation of a normal epidermis supported by increased stability of keratins 5 and 14 in keratin 10 null mice. Mol Biol Cell 2001, 12:1557-1568[Abstract/Free Full Text]
  49. Porter RM, Reichelt J, Lunny DP, Magin TM, Lane EB: The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE. J Invest Dermatol 1998, 110:951-957[Medline]
  50. Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N, Hewitt C, Moynihan L, Roberts E, Woods CG, Markham A, Wong M, Widmer R, Ghaffar KA, Pemberton M, Hussein IR, Temtamy SA, Davies R, Read AP, Sloan P, Dixon MJ, Thakker NS: Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 1999, 23:421-424[Medline]
  51. Hart TC, Hart PS, Michalec MD, Zhang Y, Firatli E, Van Dyke TE, Stabholz A, Zlotogorski A, Shapira L, Soskolne WA: Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C. J Med Genet 2000, 37:88-94[Abstract/Free Full Text]
  52. Pham CT, Ley TJ: Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci USA 1999, 96:8627-8632[Abstract/Free Full Text]
  53. Jaqueti G, Requena L, Sanche Zyus E: Trichoblastoma is the most common neoplasm developed in nevus sebaceus of Jadassohn: a clinicopathologic study of a series of 155 cases. Am J Dermatopathol 2000, 22:108-118[Medline]
  54. Prouty SM, Lawrence L, Stenn KS: Fibroblast-dependent induction of a murine skin lesion similar to human nevus sebaceus of Jadassohn. Lab Invest 1997, 76:179-189[Medline]



This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
D. Spira, J. Stypmann, D. J. Tobin, I. Petermann, C. Mayer, S. Hagemann, O. Vasiljeva, T. Gunther, R. Schule, C. Peters, et al.
Cell Type-specific Functions of the Lysosomal Protease Cathepsin L in the Heart
J. Biol. Chem., December 21, 2007; 282(51): 37045 - 37052.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Kitamoto, G. K. Sukhova, J. Sun, M. Yang, P. Libby, V. Love, P. Duramad, C. Sun, Y. Zhang, X. Yang, et al.
Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Knockout Mice
Circulation, April 17, 2007; 115(15): 2065 - 2075.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Cheng, K. Hitomi, I. M. J. J. van Vlijmen-Willems, G. J. de Jongh, K. Yamamoto, K. Nishi, C. Watts, T. Reinheckel, J. Schalkwijk, and P. L. J. M. Zeeuwen
Cystatin M/E Is a High Affinity Inhibitor of Cathepsin V and Cathepsin L by a Reactive Site That Is Distinct from the Legumain-binding Site: A NOVEL CLUE FOR THE ROLE OF CYSTATIN M/E IN EPIDERMAL CORNIFICATION
J. Biol. Chem., June 9, 2006; 281(23): 15893 - 15899.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Benavides, C. Perez, J. Blando, J.-L. Guenet, and C. J. Conti
The Radiation-Induced nackt (nkt) Allele Is a Loss-of-Function Mutation of the Mouse Cathepsin L Gene
J. Immunol., January 15, 2006; 176(2): 702 - 703.
[Full Text] [PDF]

Home page
 JCBHome page
C. Leyvraz, R.-P. Charles, I. Rubera, M. Guitard, S. Rotman, B. Breiden, K. Sandhoff, and E. Hummler
The epidermal barrier function is dependent on the serine protease CAP1/Prss8
J. Cell Biol., August 1, 2005; 170(3): 487 - 496.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
T. Reinheckel, S. Hagemann, S. Dollwet-Mack, E. Martinez, T. Lohmuller, G. Zlatkovic, D. J. Tobin, N. Maas-Szabowski, and C. Peters
The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling
J. Cell Sci., August 1, 2005; 118(15): 3387 - 3395.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Buhling, N. Waldburg, A. Reisenauer, A. Heimburg, H. Golpon, and T. Welte
Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation
Eur. Respir. J., April 1, 2004; 23(4): 620 - 628.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Zheng, P. M. Chou, B. L. Mirkin, and A. Rebbaa
Senescence-initiated Reversal of Drug Resistance: Specific Role of Cathepsin L
Cancer Res., March 1, 2004; 64(5): 1773 - 1780.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benavides, F.
Right arrow Articles by Conti, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benavides, F.
Right arrow Articles by Conti, C. J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS